- Report
- May 2021
North America
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- May 2021
Asia Pacific
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- May 2021
Middle East, Africa
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- March 2019
- 16 Pages
Global
€9556EUR$10,000USD£8,131GBP
- Report
- April 2021
- 120 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Report
- December 2021
- 109 Pages
Global
From €4300EUR$4,500USD£3,659GBP
- Report
- August 2022
Global
From €755EUR$790USD£642GBP
- Report
- August 2022
United States
From €1854EUR$1,940USD£1,577GBP
- Report
- August 2022
Global
From €946EUR$990USD£805GBP
- Report
- August 2022
Global
From €755EUR$790USD£642GBP
- Report
- August 2022
United States
From €1854EUR$1,940USD£1,577GBP
- Report
- August 2021
Europe
From €3268EUR$3,420USD£2,781GBP
- Report
- August 2021
Global
From €3813EUR$3,990USD£3,244GBP
- Report
- February 2021
Global
From €2829EUR$2,960USD£2,407GBP
- Report
- April 2022
- 94 Pages
Global
From €6685EUR$6,995USD£5,688GBP
- Report
- April 2023
- 74 Pages
Global
From €3340EUR$3,495USD£2,842GBP
- Report
- July 2019
- 44 Pages
Global
From €3818EUR$3,995USD£3,248GBP
- Report
- June 2018
- 124 Pages
Global
From €10507EUR$10,995USD£8,940GBP
- Report
- May 2023
- 162 Pages
Global
From €3371EUR$3,528USD£2,868GBP
€3966EUR$4,150USD£3,374GBP
The Allergy Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of medications used to treat allergies. Allergy drugs are used to treat a wide range of conditions, including hay fever, asthma, eczema, and food allergies. These drugs can be administered orally, topically, or through injections. Commonly used allergy drugs include antihistamines, decongestants, corticosteroids, and leukotriene modifiers.
The Allergy Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi, Pfizer, Novartis, and Johnson & Johnson. These companies are constantly developing new drugs and treatments to meet the needs of allergy sufferers. Show Less Read more